ANTABIO Raises Euro 25 Million in Series B Financing
Antabio SAS announced that it has raised Euro 25 million in a series B financing round with subscriptions from the AMR Action Fund.
Global Pharma | 13/12/2023 | By Manvi | 642
Sterling Accuris Expands into Pharmaceutical and Analytical Testing
With this acquisition, Sterling Accuris has successfully expanded its range of services offered to fields such as pharmaceutical analytical testing.
Global Pharma | 13/12/2023 | By Manvi | 422
DifGen Pharmaceuticals Acquires KriGen Pharmaceuticals LLC
DifGen Pharmaceuticals Acquires KriGen Pharmaceuticals LLC - a Sterile Dosage Manufacturing Facility in North Carolina, US, Strengthening Its Position in Developing and Manufacturing Complex Differentiated Sterile Dosage Formulations
Global Pharma | 13/12/2023 | By Manvi | 1240
ACG Inspection Launch Cloud-Based Offering Addressing VRS Requirements Under DSCSA Regulations
The new system, which forms part of the ACG’s Inspections Life Sciences Cloud Service and Compliance Gateway, enables the automatic verification of saleable returns through product identifiers by routing requests and responses between stakeholders.
Global Pharma | 13/12/2023 | By Manvi | 491
Ferring and Pharmabiome Enter A Microbiome R&D Collaboration and Licensing Agreement
Ferring Pharmaceuticals and Zürich-based microbiome translation company PharmaBiome are announcing a research & development collaboration to drive forward new microbiome-based biotherapeutics in the field of gastroenterology.
Global Pharma | 13/12/2023 | By Manvi | 484
Full-Life Technologies to Build GMP Radiopharmaceuticals Mfg. Facility
This strategic investment will enhance radiopharmaceutical production capabilities at a key logistical hub to ensure the timely supply and delivery worldwide.
Global Pharma | 13/12/2023 | By Manvi | 300
PharmaKure and UiTM Collaborate for Advance Research in Alzheimer's Disease Diagnosis
The partnership is focused on advancing research initiatives on the use of machine learning tools to predict Alzheimer’s Disease using blood via academic-industry partnerships.
Global Pharma | 12/12/2023 | By Manvi | 566
Chinese Company to Set Up Pharmaceutical Ingredients Factory in BEPZA EZ
Chinese company Crescent Hi Tech Co. Ltd. is going to set up an ‘Active Pharmaceutical Ingredients (API)’ manufacturing industry in BEPZA Economic Zone.
Global Pharma | 12/12/2023 | By Manvi | 291
Vanda Pharmaceuticals Acquires US and Canadian Rights to PONVORY
Vanda Pharmaceuticals Inc. (Vanda) announced that it has acquired US and Canadian rights to PONVORY® (ponesimod) from Actelion Pharmaceuticals Ltd. (Janssen), a Johnson & Johnson Company.
Global Pharma | 12/12/2023 | By Manvi | 239
Natco Pharma Chennai Plant Operations Disrupted Due To Cyclone
After following the required step process and safety measures, the factory operations have been shut down temporarily, the drug firm said in a regulatory filing.
Global Pharma | 12/12/2023 | By Manvi | 510
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy